RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2
Angewandte Chemie International Edition · 18.05.2026 · 65 (21)
DOI: 10.1002/anie.7837067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 06.04.2026. Verfasst von Koki Shinbara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Peptides, Cyclic, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS), Japan Science and Technology Agency.
Abstract (Originalsprache)
Backbone‐cyclic peptides (BMPs) are an attractive class of molecules appeared in diverse natural bioactive products. However, mRNA display technology coupled with ribosomal synthesis is intrinsically inapplicable to such peptide phenotypes due to loss of the C‐terminal peptide region linking to the mRNA genotypes. To overcome this issue, we have devised a new strategy to link the sidechain‐to‐S‐mainchain bond via an S ‐to‐ N acyl‐shift to connect BMPs to the C‐terminal fragment of the peptide. Here, we report the application of this strategy to construct a library of BMPs fused to cognate mRNAs. The library was applied for the selection of BMP ligands targeting Akt2, which is involved in the signal pathway to cancer pathogenesis. Consequently, BMP ligands against Akt2 were successfully uncovered from the library. The most potent Akt2 inhibitor, BMPakti‐3, showed 1.3 nM of dissociation constant and 34 nM of half‐maximal inhibitory concentration (IC 50 ). This system offers a unique platform for the de novo discovery of bioactive BMP ligands against various protein targets of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
ORCID-Profile: Hiroaki Suga
Förderung
- Japan Society for the Promotion of Science (JSPS)
- Japan Science and Technology Agency
Zitieren
APA
Shinbara, K., Yanagi, E., Aizawa, A., Katoh, T., & Suga, H. (2026). RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2. Angewandte Chemie International Edition, 65(21). https://doi.org/10.1002/anie.7837067
Vancouver
Shinbara K, Yanagi E, Aizawa A, Katoh T, Suga H. RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2. Angewandte Chemie International Edition. 2026;65(21). doi:10.1002/anie.7837067
BibTeX
@article{Shinbara2026,
author = {Shinbara, Koki and Yanagi, Ekishin and Aizawa, Ayaka and Katoh, Takayuki and Suga, Hiroaki},
title = {RaPID Selection of Backbone Macrocyclic Peptides Targeting Akt2},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {21},
doi = {10.1002/anie.7837067}
}
EUVIMED